FOXO Technologies 

$0.01
45
-$0-36.71% Today

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0.01
Volume
5,500
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-334.78%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
8.1MRevenue
-27.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FOXOW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomics solutions, competing in the biotech space similar to FOXO's focus on leveraging biotech for life insurance underwriting.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers sequencing systems that rival FOXO's biotech approaches in analyzing genetic data for health insights.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health focuses on cancer diagnostics through genomic insights, competing with FOXO's approach to leveraging genetic information.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences provides cancer screening and diagnostic tests, competing in the genomic analysis space similar to FOXO.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is involved in gene editing, a technology that could rival FOXO's genomic data applications in healthcare and insurance.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics works on CRISPR gene editing, potentially competing with FOXO's applications of genetic data.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine is focused on gene editing, directly competing with FOXO's use of genetic insights for health and insurance solutions.
Teladoc Health
TDOC
Mkt Cap1.53B
Teladoc Health offers virtual healthcare services, indirectly competing with FOXO by providing alternative health management solutions.
Ginkgo Bioworks
DNA
Mkt Cap769M
Ginkgo Bioworks engineers organisms for customers across industries, including healthcare, potentially competing with FOXO's biotech applications.

About

FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.
Show more...
CEO
Mr. Seamus Lagan
Employees
102
Country
US
ISIN
US3514711155

Listings

0 Comments

Share your thoughts

FAQ

What is FOXO Technologies stock price today?
The current price of FOXOW is $0.01 USD — it has decreased by -36.71% in the past 24 hours. Watch FOXO Technologies stock price performance more closely on the chart.
What is FOXO Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange FOXO Technologies stocks are traded under the ticker FOXOW.
What is FOXO Technologies revenue for the last year?
FOXO Technologies revenue for the last year amounts to 8.1M USD.
What is FOXO Technologies net income for the last year?
FOXOW net income for the last year is -27.12M USD.
How many employees does FOXO Technologies have?
As of April 02, 2026, the company has 102 employees.
In which sector is FOXO Technologies located?
FOXO Technologies operates in the Health Care sector.
When did FOXO Technologies complete a stock split?
FOXO Technologies has not had any recent stock splits.
Where is FOXO Technologies headquartered?
FOXO Technologies is headquartered in West Palm Beach, US.